
Immunovant, Inc.
IMVTNASDAQHealthcare● Active
$30.80
$-0.31(-1.00%)
Market Cap$6.3B
P/E Ratio—
52W High$36.285
52W Low$14.32
Immunovant, Inc. (IMVT) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IMVT · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.51B) | ($0.41B) | ($0.26B) | ($0.21B) | ($0.16B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.06B | $0.05B | $0.04B | $0.03B | $0.03B |
| Change in Working Capital | $0.04B | ($0.01B) | $0.00B | ($0.01B) | $0.02B |
| Net Cash from Operations | ($0.41B) | ($0.38B) | ($0.21B) | ($0.19B) | ($0.11B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.60B | $0.45B | $0.47B | $0.07B | $0.20B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.41B) | ($0.38B) | ($0.21B) | ($0.19B) | ($0.11B) |
| FCF Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Immunovant, Inc. data
About Immunovant, Inc. (IMVT) Cash Flow Statement
Immunovant, Inc. generated operating cash flow of ($0.41B) and free cash flow of ($0.41B) for 2026 — a FCF margin of —. Capital expenditure was ($0.00B).
Frequently asked questions
IMVT · 4 questionsImmunovant, Inc. generated free cash flow of ($0.41B) for 2026, down 8.1% year-over-year.
IMVT free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10